Akari Therapeutics Company
Auto-immune diseases. Develop life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2005
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership